Sanara MedTech Inc.

NasdaqCM:SMTI Stock Report

Market Cap: US$218.8m

Sanara MedTech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SMTI?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,531,13916.7%
General Public2,206,22424.1%
Private Companies2,547,93427.8%
Individual Insiders2,878,67231.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 70.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.8%
Catalyst Rochal, Llc
2,547,934US$60.8m0%no data
11.3%
Ronald Nixon
1,032,052US$24.6m0.4%no data
10.6%
James Stuckert
966,972US$23.1m0%no data
5.35%
S. Howell
490,394US$11.7m0%no data
2.5%
BlackRock, Inc.
228,767US$5.5m6.96%no data
1.65%
Vanguard Capital Management, LLC
151,367US$3.6m0%no data
1.49%
Stonebridge Wealth Management, LLC
136,899US$3.3m1.46%3.01%
1.28%
Royal Bank of Canada
117,753US$2.8m13.2%no data
1.2%
Seth Yon
109,546US$2.6m-3.4%no data
0.93%
Geode Capital Management, LLC
85,662US$2.0m8.37%no data
0.83%
Marshall Wace LLP
76,282US$1.8m56.9%no data
0.8%
Squarepoint OPS LLC
73,607US$1.8m50.4%no data
0.71%
Renaissance Technologies LLC
64,680US$1.5m72%no data
0.68%
State Street Global Advisors, Inc.
62,689US$1.5m0.64%no data
0.43%
AQR Capital Management, LLC
39,071US$933.0k0%no data
0.42%
Jane Street Group, LLC
38,584US$921.4k154%no data
0.37%
Zachary Fleming
34,162US$815.8k0%no data
0.36%
Northern Trust Global Investments
33,256US$794.2k3.71%no data
0.34%
Citadel Advisors LLC
31,113US$743.0k207%no data
0.31%
Bob DeSutter
28,740US$686.3k23.9%no data
0.31%
Michael McNeil
28,587US$682.7k0%no data
0.3%
BNP Paribas Financial Markets SNC
27,698US$661.4k537%no data
0.29%
Ann Salamone
26,858US$641.4k18.3%no data
0.29%
Qube Research & Technologies Ltd
26,409US$630.6k0%no data
0.28%
Sara Ortwein
25,415US$606.9k22.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/10 11:21
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sanara MedTech Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ilya ZubkovFreedom Broker
Yi ChenH.C. Wainwright & Co.
Frank TakkinenLake Street Capital Markets, LLC